Inventor · disambiguated record
Matthew C. Rhodes
Also filed as: RHODES MATTHEW C
4 granted patents·6 pending applications·21 citations·filing 2021–2025
67Inventor score
Files withENANTA PHARM INC10
Top patents by PatentIndex Score
10 records- 0198US11325916B1Spiropyrrolidine derived antiviral agentsENANTA PHARM INC·Filed 2021·Granted May 10, 2022·16 cites·15 claims
- 0296US11919910B2Spiropyrrolidine derived antiviral agentsENANTA PHARM INC·Filed 2022·Granted Mar 5, 2024·5 cites·13 claims
- 0368US2024327334A1Covalent Inhibitors As Antiviral AgentsENANTA PHARM INC·Filed 2023·Application pending·0 cites
- 0466US2024207224A1Macrocyclic chalcone-amide derived antiviral agentsENANTA PHARM INC·Filed 2023·Application pending·0 cites
- 0566US2025059174A1Pharmaceutical Compounds and Compositions as C-Kit Kinase InhibitorsENANTA PHARM INC·Filed 2024·Application pending·0 cites
- 0664US2025042898A1Pharmaceutical Compounds And Compositions As c-Kit Kinase InhibitorsENANTA PHARM INC·Filed 2024·Application pending·0 cites
- 0763US12145942B2Spiropyrrolidine derived antiviral agentsENANTA PHARM INC·Filed 2023·Granted Nov 19, 2024·0 cites·13 claims
- 0863US2025034138A1Compounds and Compositions as C-Kit Kinase InhibitorsENANTA PHARM INC·Filed 2024·Application pending·0 cites
- 0958US12479854B2Spiropyrrolidine derived antiviral agentsENANTA PHARM INC·Filed 2022·Granted Nov 25, 2025·0 cites·22 claims
- 1046US2025304600A1PHARMACEUTICAL COMPOUNDS AND COMPOSITIONS AS c-KIT KINASE INHIBITORSENANTA PHARM INC·Filed 2025·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Matthew C. Rhodes files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →